“This study investigates the anticancer properties of cannabisin B, purified from hempseed hull, in HepG2 human hepatoblastoma cells.
The results indicate that cannabisin B significantly inhibited cell proliferation by inducing autophagic cell death rather than typical apoptosis.
Cell viability transiently increased upon the addition of a low concentration of cannabisin B but decreased upon the addition of high concentrations.
Cannabisin B-induced changes in cell viability were completely inhibited by pre-treatment with 3-methyladenine (3-MA), indicating that the induction of autophagy by cannabisin B caused cell death.
Additionally, cannabisin B induced S phase cell cycle arrest in a dose-dependent manner.
Moreover, cannabisin B was found to inhibit survival signaling by blocking the activation of AKT and down-stream targets of the mammalian target of rapamycin (mTOR).
These findings suggest that cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease.”
http://www.ncbi.nlm.nih.gov/pubmed/23411211
http://www.thctotalhealthcare.com/category/liver-cancer-2/
